236 related articles for article (PubMed ID: 33252031)
1. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
Aldahham BJM; Al-Khafaji K; Saleh MY; Abdelhakem AM; Alanazi AM; Islam MA
J Biomol Struct Dyn; 2022 Jun; 40(9):3899-3906. PubMed ID: 33252031
[TBL] [Abstract][Full Text] [Related]
2. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.
Mohammad A; Alshawaf E; Marafie SK; Abu-Farha M; Al-Mulla F; Abubaker J
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919870
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16.
Klima M; Khalili Yazdi A; Li F; Chau I; Hajian T; Bolotokova A; Kaniskan HÜ; Han Y; Wang K; Li D; Luo M; Jin J; Boura E; Vedadi M
Protein Sci; 2022 Sep; 31(9):e4395. PubMed ID: 36040262
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
Maurya SK; Maurya AK; Mishra N; Siddique HR
J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
[TBL] [Abstract][Full Text] [Related]
5.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10.
Zhao H; Liu J; He L; Zhang L; Yu R; Kang C
Biochem Biophys Res Commun; 2022 Oct; 626():114-120. PubMed ID: 35988295
[TBL] [Abstract][Full Text] [Related]
7. Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2'-
Eissa IH; Alesawy MS; Saleh AM; Elkaeed EB; Alsfouk BA; El-Attar AMM; Metwaly AM
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408684
[TBL] [Abstract][Full Text] [Related]
8. Binding of the Methyl Donor
Aouadi W; Blanjoie A; Vasseur JJ; Debart F; Canard B; Decroly E
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031370
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
Chen Y; Su C; Ke M; Jin X; Xu L; Zhang Z; Wu A; Sun Y; Yang Z; Tien P; Ahola T; Liang Y; Liu X; Guo D
PLoS Pathog; 2011 Oct; 7(10):e1002294. PubMed ID: 22022266
[TBL] [Abstract][Full Text] [Related]
10. Computational investigation of potent inhibitors against SARS-CoV-2 2'-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations.
Shi L; Wen Z; Song Y; Wang J; Yu D
J Mol Graph Model; 2022 Dec; 117():108306. PubMed ID: 36063745
[TBL] [Abstract][Full Text] [Related]
11. Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 Complex from SARS-CoV-2.
Balieiro AM; Anunciação ELS; Costa CHS; Qayed WS; Silva JRA
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430451
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.
Savale RU; Bhowmick S; Osman SM; Alasmary FA; Almutairi TM; Abdullah DS; Patil PC; Islam MA
Arch Biochem Biophys; 2021 Mar; 700():108771. PubMed ID: 33485847
[TBL] [Abstract][Full Text] [Related]
13. A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19.
Perveen S; Khalili Yazdi A; Devkota K; Li F; Ghiabi P; Hajian T; Loppnau P; Bolotokova A; Vedadi M
SLAS Discov; 2021 Jun; 26(5):620-627. PubMed ID: 33423577
[TBL] [Abstract][Full Text] [Related]
14. Integrated molecular and quantum mechanical approach to identify novel potent natural bioactive compound against 2'-O-methyltransferase (nsp16) of SARS-CoV-2.
Thomas J; Kumar S; Satija J
J Biomol Struct Dyn; 2024; 42(4):1999-2012. PubMed ID: 37129206
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16.
Wu K; Guo Y; Xu T; Huang W; Guo D; Cao L; Lei J
Molecules; 2024 May; 29(10):. PubMed ID: 38792173
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamic simulations reveal anti-SARS-CoV-2 activity of mitocurcumin by potentially blocking innate immune evasion proteins NSP3 and NSP16.
Pal D; Checker R; Kutala VK; Sandur SK
Mol Divers; 2023 Apr; 27(2):635-649. PubMed ID: 35538380
[TBL] [Abstract][Full Text] [Related]
17. Cheminformatics approach to identify andrographolide derivatives as dual inhibitors of methyltransferases (nsp14 and nsp16) of SARS-CoV-2.
Thomas J; Ghosh A; Ranjan S; Satija J
Sci Rep; 2024 Apr; 14(1):9801. PubMed ID: 38684706
[TBL] [Abstract][Full Text] [Related]
18. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex.
Khalili Yazdi A; Li F; Devkota K; Perveen S; Ghiabi P; Hajian T; Bolotokova A; Vedadi M
SLAS Discov; 2021 Jul; 26(6):757-765. PubMed ID: 33874769
[TBL] [Abstract][Full Text] [Related]
19. Molecular Interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 Protein Complex.
Alnomasy SF; Alotaibi BS; Aldosari ZM; Mujamammi AH; Alzamami A; Anand P; Akhter Y; Khan FR; Hasan MR
Comb Chem High Throughput Screen; 2023; 26(6):1196-1203. PubMed ID: 35975856
[TBL] [Abstract][Full Text] [Related]
20. Identification and structural studies of natural inhibitors against SARS-CoV-2 viral RNA methyltransferase (NSP16).
Kumar M; Roy A; Rawat RS; Alok A; Tetala KKR; Biswas NR; Kaur P; Kumar S
J Biomol Struct Dyn; 2022; 40(24):13965-13975. PubMed ID: 34766876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
